more on UBS here:http://www.theage.com.au/business/ubs-at-the-centre-of-mystery-bluechip-trades-20121023-282ms.html
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago